Healthcare - Biotechnology - NASDAQ - US
$ 14.37
-0.76 %
$ 101 M
Market Cap
-0.6
P/E
CASH FLOW STATEMENT
-22.4 M
OPERATING CASH FLOW
-505 K
INVESTING CASH FLOW
26 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Cidara Therapeutics, Inc.
| Net Income | -22.9 M |
| Depreciation & Amortization | 118 K |
| Capital Expenditures | -505 K |
| Stock-Based Compensation | 3.06 M |
| Change in Working Capital | -3.92 M |
| Others | 4.94 M |
| Free Cash Flow | -22.9 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (22.9) | (29.8) | (42.5) | (72.1) | (41.1) | (59.0) | (55.7) | (48.2) | (32.2) | (11.9) | (1.3) | (0.8) |
| Depreciation & Amortization | 0.1 | 1.2 | (1.2) | 0.2 | 0.4 | 0.5 | 0.7 | 0.7 | 0.5 | 0.2 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | (0.4) | (3.6) | 33 K | (0.2) | 42 K | 0 | 0 | 0 |
| Stock Based Compensation | 3.1 | 3.5 | 4.0 | 4.1 | 5.1 | 5.7 | 5.7 | 4.3 | 3.0 | 0.2 | 11 K | 0 |
| Other Operating Activities | 1.2 | 1 K | 15 K | 21 K | 36 K | 86 K | 50 K | 14 K | 76 K | 1.9 | 0.3 | 0.8 |
| Change in Working Capital | (3.9) | (3.4) | 14.4 | 13.4 | 7.5 | (0.4) | (0.6) | 3.5 | 2.7 | 1.9 | 23 K | 0 |
| Cash From Operations | (22.4) | (28.5) | (25.2) | (54.4) | (28.5) | (56.7) | (49.9) | (39.8) | (26.0) | (7.7) | (1.0) | 0 |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (0.5) | (0.1) | 41 K | (0.2) | 35 K | (0.2) | (0.3) | (0.4) | (1.2) | (1.0) | 0 | 0 |
| Other Items | 0 | 0 | 0 | 0 | 0 | 14.5 | 4.8 | 25.9 | (44.9) | 0 | 0 | 0 |
| Cash From Investing Activities | (0.5) | (0.1) | 41 K | (0.2) | 35 K | 14.3 | 4.5 | 25.5 | (46.1) | (1.0) | 0 | 0 |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 79 K | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | (2.6) | (4.4) | (3.0) | 0 | 0 | 0 | 9.9 | 0 | 0.9 | 1.2 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 21 K | (0.7) | 6 K | 14 K | 24 K | 49.7 | 0.2 | 0.5 | 42.3 | 30.4 | 0 | 12 K |
| Cash From Financing Activities | 26.0 | (1.0) | 44.6 | 37.3 | 14.3 | 56.2 | 20.9 | 37.1 | 111.8 | 31.3 | 1.2 | 12 K |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 3.0 | (29.5) | 19.3 | (17.3) | (14.3) | 13.7 | (24.6) | 22.8 | 39.8 | 22.6 | 0.2 | 12 K |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (22.9) | (28.6) | (25.3) | (54.6) | (28.6) | (56.9) | (50.2) | (40.2) | (27.1) | (8.7) | (1.0) | 0 |